摘要
目的分析磺胺嘧啶在家兔体内药动学过程。方法20只家兔耳缘静脉快速推注磺胺嘧啶300mg·kg-1,752紫外分光光度计比色法测定不同时间的血药浓度并计算药动学参数。结果磺胺嘧啶在家兔体内药-时曲线符合二室模型,并表现为快慢两种速率类型。慢消除型药动学参数为:VC=(0.24±0.09)L·kg-1,V=(0.62±0.22)L·kg-1,AUC=(0.11±0.05)g·h·mL-1,CL=(3.8±1.5)mL·min-1,t1/2α=(3.3±1.3)min,t1/2β=(122±21)min。快消除型药动学参数为:VC=(0.19±0.10)L·kg-1,V=(0.45±0.17)L·kg-1,AUC=(0.062±0.022)g·h·mL-1,CL=(6.0±2.4)mL·min-1,t1/2α=(2.1±0.9)min,t1/2β=(53±5)min。与慢消除型比较,快消除型AUC减少,CL增加,P<0.05;t1/2β缩短,P<0.001。结论磺胺嘧啶在家兔体内药动学过程表现为快慢两种速率类型。快消除型AUC减少,CL增加,t1/2β缩短。本实验为磺胺嘧啶的临床给药方案制定提供了实验依据。
Abstract
OBJECTIVE To analyze pharmacokinetic parameters of sulfadiazine in rabbits.METHODS A single dose of 300 mg·kg-1 sulfadiazine was given intravenously to 20 healthy rabbits.The concentrations of sulfadiazine in different time and were determined by ultraviolet spectrophotometer and pharmacokinetic parameters were calculated. RESULTS The time-concentration curve of sulfadiazine in rabbit coincided with the two-compartment open model. Slow and fast rate-metabolism for sulfadiazine were distinguished in this study. The pharmacokinetic parameters of slow rate-metabolism were as follows:VC (0.24±0.09) L·kg-1,V(0.62±0.22)L·kg-1,AUC(0.11±0.05)g·h·mL-1,CL(3.8±1.5) mL·min-1,t1/2α(3.3±1.3)min,t1/2β(122±21)min. The pharmacokinetic parameters of fast rate-metabolism were as follows: VC(0.19±0.10)L·kg-1,V(0.45±0.17)L·kg-1,AUC(0.062±0.022)g·h·mL-1,CL(6.0±2.4)mL·min-1,t1/2α(2.1±0.9) min,t1/2β(53±5) min. When being compared with that of slow rate-metabolism,AUC,t1/2β of fast rate-metabolism were significantly decreased,CL of fast rate-metabolism was significantly increased. CONCLUSION Slow and fast rate-metabolism for sulfadiazine in rabbit can be distinguished. This study provides a scientific basis for clinical use of sulfadiazine.
关键词
磺胺嘧啶 /
家兔 /
药动学
{{custom_keyword}} /
Key words
sulfadiazine /
rabbit /
pharmacokinetics
{{custom_keyword}} /
覃冬云;鲁澄宇;许卫铭;吴铁.
家兔单剂量静脉注射磺胺嘧啶的药动学[J]. 中国药学杂志, 2007, 42(22): 1733-1735
QIN Dong-yun;LU Deng-yu;XU Wei-ming;WU Tie.
Study on Pharmacokinetic of a Single Dose of Intravenous Sulfadiazine in Rabbits [J]. Chinese Pharmaceutical Journal, 2007, 42(22): 1733-1735
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] LIU J,GUO Z Z. Progression about new approach for pityrosporion ovale pneumonia[J] .Chin J Tuberc Respir Dis(中华结核和呼吸系统疾病杂志),2006,29(2):121-123.
[2] MUANGMAN P, CHUNTRASAKUL C, SILTHRAM S,et al. Comparison of efficacy of 1% silver sulfadiazine and acticoat for treatment of partial-thickness burn wounds[J] .J Med Assoc Thai,2006,89(7):953-958.
[3] YUE X Y,YANG S P,CHENG J,et al. Determination of sulfonamides residuesinanimal muscle by HPLC means[J] .Sichuan Anim Vet Sci(四川畜牧兽医),2005,32(2):27-28.
[4] LI Y P,ZHAO M Y,DUAN Q X,et al. Studies on the pharmacokinetics of sulfadiazinum in rabbits with experimental reduced renal functions[J] .Animal Toxicology(动物毒物学),2004,19(1):14-19.
[5] CHENG Z S H,XIE M M,LUO Y P. First study for “soludagenan pharmacokineticsassay in rabbit” [J] .Chin J Med Writing(中华医学写作杂志),2004,11(8):691-692.
[6] BARRAVIERA B,PEREIRA P C,MEADES R P,et al. Evaluation of acetylator phenotype,renal function and serum sulfadiazine levels in patients with paracoccidioidomycosis treated with cotrimazine (a combination of sulfadiazine and trimethoprim) [J] . Mycopathologia,1989,108(2):107-112.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}